Investing in promising cancer treatments, putting patient needs first
Independent research fund focusing on cancer treatments

Driven by patients,
guided by science and
powered by your donations

We support scientific research and outstanding care for cancer patients.

The Anticancer Fund is a Belgian non-profit organisation with an international scope. We depend fully on donations and private funding to finance our work.

We believe in the power of science to find solutions for cancer patients. We invest in clinical trials for more and better treatments. Because cancer patients deserve optimal treatment.

Discover the trials we fund

OUR PROMISE

In the news

20Jul2021

Sarcoma awareness month

The issues that we highlighted last year are still true. However, there are signs of change on the horizon.
Read the blog
05Jul2021

765 trials with potential cancer drugs

There's a huge potential in existing drugs, to be used against cancer. We listed 765 active trials where non-cancer drugs are tested on their anticancer effects.
Explore the database
02Jul2021

First patient for trial in rare cancers

EORTC 1945 OligoRARE enrolled its first patient in Antwerp, Belgium. The trial is a phase 3 study evaluating radiotherapy in addition to standard of care treatment for patients with oligometastatic rare cancers. We fund this trial.
Read more
24Jun2021

Latest news about drug repurposing in oncology #8

Discover our latest newsletter with scientific updates and recent findings about the repurposing of generic drugs in oncology.
Read the newsletter
08Jun2021

Are repurposed drugs ready for use in cancer?

We often get questions of cancer patients about drug repurposing through our personal service My Cancer Navigator: they are wondering if today we can use some drugs, developed for other conditions, for the treatment of cancer. And if we can, which ones?
Read the blog
27May2021

What about vaccines against cancer?

Our researchers reviewed approved vaccines and found 16 with data supporting a cancer therapeutic use. The use of these vaccines is particularly interesting given the increased use of immunotherapy treatments in cancer, particularly the use of immune checkpoint inhibitors.
Read more

WE MAKE A DIFFERENCE

  • invest in research icon

    We invest in research

    We put science to work for patients and we strive for short-term, meaningful impacts where they are most needed.
    Read more
  • Involve in clinical trials icon

    We set up clinical trials

    We are an independent, non-profit intermediary and focus on clinical research with limited economic value.
    Read more
  • Connect stakeholders icon

    We connect people

    As we are just a small part of the enormous cancer research ecosystem, we don't act alone.
    Read more
  • Advise professionals icon

    We advise professionals

    According to our mission and vision, we provide free advice in designing trials and reviewing scientific research.
    Read more
  • Inform patients icon

    We help cancer patients

    We personally answer therapy-related questions from patients and provide non-judgmental information.
    Read more

Our current focus areas

  • Drug repurposing

    Drug repurposing, also known as drug repositioning, is a drug development strategy predicated on the reuse of existing...
    Read more

  • Less common and rare cancers

    We don’t just focus on the ‘big four’ of cancer – prostate, colon, breast and lung. We also investigate new treatment...
    Read more

  • Combination therapies

    It is important to investigate the impacts of drugs beyond what they can achieve alone. Using them in combination...
    Read more

  • Preventing tumour recurrence

    For cancer survivors, the fight isn’t always over. Many are concerned about the possibility of recurrence, and living...
    Read more